Ex parte JONES - Page 2




               Appeal No. 1996-0848                                                                                                   
               Application 07/624,053                                                                                                 


                       22.     A continuous cell line producing a human monocyte cytotoxicity inducing                                
               factor, the factor characterized by the following properties:                                                          
                       (a)     capability of inducing human monocytes to a cytotoxic state;                                           
                       (b)     retention of biological activity following treatment at pH 2 for one hour;                             
                                                                                               B                                      
                       (c)     retention of biological activity following treatment at 60 C for one hour;                             
                       (d)     ability to bind to Matrex Gel Red A under low-salt conditions and elute                                
               from Matrex Gel Red A under high-salt conditions; and                                                                  
                       (e)     retention of biological activity in the presence of antiserum to interferon                            
               gamma, interferon alpha, or a combination of anti-sera to interferon alpha                                             
               and gamma.                                                                                                             

                       25.     A continuous cell line which produces a factor capable of inducing human                               
               monocytes to a cytotoxic state, the continuous cell line being produced by a process                                   
               comprising the steps of:                                                                                               

               (a)  immortalizing human T-cells to produce continuous cell clone;                                                     
               (b) identifying a clone which produces a human monocyte cytotoxicity inducing factor                                   
               having the following properties:                                                                                       
                               i)  capability of inducing human monocytes to a cytotoxic state;                                       
                               ii) retention of biological activity following treatment at pH 2 for one hour;                         
                                                                                                  B                                   
                               iii) retention of biological activity following treatment at 60 C for one hour;                        
                               iv) ability to bind to Matrex Gel Red A under low-salt conditions and elute                            
               from Matrix Gel Red A under high-salt conditions; and                                                                  




                                                                  2                                                                   





Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  Next 

Last modified: November 3, 2007